Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 82
- 试验地点
- 2
- 主要终点
- Value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment
研究概览
简要总结
From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient.
Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity.
The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management.
This new organisation is part of the policy of continuous improvement of the quality and safety of care
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hospitalized patient
- •Patient with a drug treatment with a particular mode of supply
- •Paediatric patient or an adult patient.
- •First inpatient stay over the inclusion period from late 2021 to late 2022
排除标准
- •Patient under curatorship or guardianship
- •Patient residing abroad
- •No free, informed and written consent obtained
研究组 & 干预措施
Drug reconciliation
Drug reconciliation and transmission to pharmacist
干预措施: Drug reconciliation (Other)
standard
结局指标
主要结局
Value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment
时间窗: 1 month after inclusion
Value of coordinated pathway is evaluated by number of days of treatment interruption between patient discharge and provision of treatment to the patient
次要结局
未报告次要终点
